1. Home
  2. TAOP vs PHIO Comparison

TAOP vs PHIO Comparison

Compare TAOP & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAOP
    SELLHOLDBUYas of 13 hours ago
  • PHIO
    SELLHOLDBUYas of 13 hours ago
  • Stock Information
  • Founded
  • TAOP 1993
  • PHIO 2011
  • Country
  • TAOP China
  • PHIO United States
  • Employees
  • TAOP N/A
  • PHIO N/A
  • Industry
  • TAOP Computer Software: Prepackaged Software
  • PHIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TAOP Technology
  • PHIO Health Care
  • Exchange
  • TAOP Nasdaq
  • PHIO Nasdaq
  • Market Cap
  • TAOP 2.2M
  • PHIO 2.3M
  • IPO Year
  • TAOP N/A
  • PHIO N/A
  • Fundamental
  • Price
  • TAOP $0.42
  • PHIO $2.23
  • Analyst Decision
  • TAOP
  • PHIO Strong Buy
  • Analyst Count
  • TAOP 0
  • PHIO 1
  • Target Price
  • TAOP N/A
  • PHIO $36.00
  • AVG Volume (30 Days)
  • TAOP 8.4M
  • PHIO 886.2K
  • Earning Date
  • TAOP 09-05-2024
  • PHIO 11-14-2024
  • Dividend Yield
  • TAOP N/A
  • PHIO N/A
  • EPS Growth
  • TAOP N/A
  • PHIO N/A
  • EPS
  • TAOP 0.50
  • PHIO N/A
  • Revenue
  • TAOP $42,636,173.00
  • PHIO N/A
  • Revenue This Year
  • TAOP N/A
  • PHIO N/A
  • Revenue Next Year
  • TAOP N/A
  • PHIO N/A
  • P/E Ratio
  • TAOP $0.64
  • PHIO N/A
  • Revenue Growth
  • TAOP 37.49
  • PHIO N/A
  • 52 Week Low
  • TAOP $0.30
  • PHIO $1.53
  • 52 Week High
  • TAOP $2.01
  • PHIO $10.35
  • Technical
  • Relative Strength Index (RSI)
  • TAOP 64.03
  • PHIO 42.62
  • Support Level
  • TAOP $0.30
  • PHIO $1.53
  • Resistance Level
  • TAOP $0.83
  • PHIO $3.00
  • Average True Range (ATR)
  • TAOP 0.07
  • PHIO 0.39
  • MACD
  • TAOP 0.01
  • PHIO -0.08
  • Stochastic Oscillator
  • TAOP 22.64
  • PHIO 44.36

Stock Price Comparison Chart: TAOP vs PHIO

TAOP
PHIO
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober020406080100120140160TAOP VS PHIO

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use